SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 40 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $23,000 | -11.5% | 88,669 | +144.5% | 0.00% | +50.0% |
| Q3 2019 | $26,000 | +52.9% | 36,266 | +56.4% | 0.00% | +100.0% |
| Q2 2019 | $17,000 | -83.2% | 23,184 | -37.5% | 0.00% | -80.0% |
| Q1 2018 | $101,000 | +405.0% | 37,117 | +267.7% | 0.01% | +400.0% |
| Q3 2017 | $20,000 | – | 10,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,600,000 | $1,092,000 | 1.15% |
| BVF INC/IL | 2,287,860 | $951,000 | 0.12% |
| Eventide Asset Management | 2,265,455 | $942,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 400,140 | $166,000 | 0.04% |
| RP Management, LLC | 129,517 | $54,000 | 0.04% |
| Palo Alto Investors LP | 1,162,473 | $483,000 | 0.03% |
| NEA Management Company, LLC | 1,298,274 | $539,000 | 0.02% |
| Rhenman & Partners Asset Management AB | 377,244 | $157,000 | 0.02% |
| GREAT POINT PARTNERS LLC | 317,962 | $132,000 | 0.02% |
| Vivo Capital, LLC | 195,474 | $81,000 | 0.01% |